Capricor faces shareholder lawsuit over Deramiocel FDA disclosure claims

The proposed class action targets investors who bought shares between Dec. 17, 2025 and July 26, 2026, with a Sept. 28, 2026 deadline to seek lead plaintiff status.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.